Definition And Temporal Thresholds
- Adopts a dual-timepoint framework to standardize intervention.
- Timepoint $t_1$ (Treatment Initiation): Fixed at 5 minutes; marks the threshold where spontaneous seizure termination is unlikely and urgent pharmacological intervention must begin.
- Timepoint $t_2$ (Neuronal Injury Threshold): Fixed at 30 minutes for convulsive status epilepticus (SE); defines the window beyond which prolonged ictal activity causes irreversible cellular injury and permanent synaptic reorganization.
Stabilization Phase
- Ensure airway patency, breathing, and circulation (ABC).
- Place the child in the recovery position and administer supplemental oxygen.
- Check bedside blood glucose immediately.
Pharmacological Management Algorithm
| Phase | Timing | Recommended Interventions And Dosages | Key Principles |
|---|---|---|---|
| First-Line | 5-15 mins | - Lorazepam: $0.1\text{ mg/kg}$ IV (max 4 mg).- Midazolam: $0.2\text{ mg/kg}$ IM/IN/buccal (if IV access is unavailable). | Strictly limit benzodiazepines to a maximum of two doses to prevent life-threatening respiratory depression and avoidable intubations. IN/buccal midazolam is preferred over rectal diazepam due to faster mucosal absorption. |
| Second-Line | 15-20 mins | - Levetiracetam: $40-60\text{ mg/kg}$ IV over 5-10 mins.- Sodium Valproate: $20-40\text{ mg/kg}$ IV over 5-10 mins.- Fosphenytoin/Phenytoin: $20\text{ mg PE/kg}$ IV. | Equiefficacy concept applies based on large trials (ESETT, ECLIPSE). Phenytoin is no longer the absolute preferred choice; Levetiracetam and Valproate are prioritized for superior cardiorespiratory stability. Valproate is contraindicated if mitochondrial cytopathy or urea cycle defects are suspected. |
| Third-Line | >30 mins | - Midazolam Infusion: Load $0.1-0.2\text{ mg/kg}$, then maintain at $1-5\text{ mcg/kg/min}$.- Ketamine/Isoflurane: Considered for refractory cases. | Prepare for intubation and urgent transfer to the Pediatric Intensive Care Unit (PICU). |
Refractory Status Epilepticus (RSE) And Advanced Care
- Seizures persisting 10-15 minutes after a second-line anti-seizure medication (ASM) load define RSE, mandating immediate PICU admission.
- Early Ketamine Integration: Positioned earlier in RSE pathways to target NMDA-receptor upregulation caused by prolonged seizure activity.
- Continuous Video-EEG (cEEG): Urgently indicated to diagnose Non-Convulsive Status Epilepticus (NCSE), which affects up to 30% of children presenting with persistent, unexplained post-ictal encephalopathy.
- New-Onset Refractory Status Epilepticus (NORSE) Protocol: Early initiation of immunomodulatory agents (corticosteroids, IVIG) within 48-72 hours is recommended for children presenting without an obvious infectious trigger.
Specific Etiological Considerations
- Brivaracetam is emerging as an effective, well-tolerated conditional second-line option.
- An empirical pyridoxine trial should be administered concurrently in neonates or suspected metabolic cases.
- Integrate the Phoenix Criteria for recognizing and managing concurrent sepsis-associated SE.